Flow-Mediated Dilation: Can New Approaches Provide Greater Mechanistic Insight into Vascular Dysfunction in Preeclampsia and Other Diseases?

Current Hypertension Reports

Volumn 16, Issue 11, 2014, Pages 1-10

  Weissgerber, Tracey L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Brachial artery reactivity testing; Endothelial dysfunction; Flow mediated dilation; Low flow mediated constriction; Preeclampsia; Pregnancy; Shear rate area under the curve; Shear stimulus

Indexed keywords

CLINICAL PROTOCOL; ENDOTHELIAL DYSFUNCTION; FLOW MEDIATED DILATION; FUNCTION TEST; HUMAN; LOW FLOW MEDIATED CONSTRICTION; MEASUREMENT; NON INVASIVE PROCEDURE; PREECLAMPSIA; PUERPERIUM; REVIEW; BRACHIAL ARTERY; FEMALE; GENETIC SCREENING; HYPERTENSION; PATHOPHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; GENETIC TESTING; HUMANS; HYPERTENSION; PRE-ECLAMPSIA; PREGNANCY; VASCULAR DISEASES;

EID: 84910128449     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-014-0487-z     Document Type: Review

References (79)

1. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA et al. Assessment of flow mediated dilation in humans: a methodological and technical guideline. Am J Physiol Heart Circ Physiol. 2011;300 (1):H2:H12. This guideline describes provides detailed information on new methodologies recommended for FMD testing.
2. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340(8828):1111–5.
3. Green DJ, Dawson EA, Groenewoud HM, Jones H, Thijssen DH. Is flow-mediated dilation nitric oxide mediated? A meta-analysis. Hypertension. 2014;63(2):376–82.
4. Harris RA, Nishiyama SK, Wray DW, Richardson RS. Ultrasound assessment of flow-mediated dilation. Hypertension. 2010;55(5):1075–85.
5. Atkinson G, Batterham AM. Allometric scaling of diameter change in the original flow-mediated dilation protocol. Atherosclerosis. 2013;226(2):425–7.
6. Atkinson G, Batterham AM, Thijssen DH, Green DJ. A new approach to improve the specificity of flow-mediated dilation for indicating endothelial function in cardiovascular research. J Hypertens. 2013;31(2):287–91. This guideline describes detailed methodologies of new protocols for conducting FMD studies.
7. Stoner L, Faulkner J, Sabatier MJ. Is allometric scaling really a panacea for flow-mediated dilation? Commentary on paper by Atkinson and Batterham. Atherosclerosis. 2013;228(1):280–1.
8. Woodman RJ, Mangoni AA. Adjusting for brachial artery diameter in the analysis of flow-mediated dilatation: pitfalls of a landmark paper? Atherosclerosis. 2013;228(1):277–9.
9. DeVan AE, Pierce GL, Brooks FA, Seals DR. The dependence of FMD% on baseline diameter: a problem solved by allometric scaling—no problem in this case. Clin Sci (Lond). 2013;125(1):55–6.
10. Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G. Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? Hypertension. 2011;57(3):363–9. This meta-analysis shows that flow-mediated dilation measured above and below the cuff both predict future cardiovascular events.
11. Shechter M, Issachar A, Marai I, Koren-Morag N, Freinark D, Shahar Y, et al. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol. 2009;134(1):52–8.
12. Shechter M, Marai I, Marai S, Sherer Y, Sela BA, Feinberg MS, et al. The association of endothelial dysfunction and cardiovascular events in healthy subjects and patients with cardiovascular disease. Isr Med Assoc J. 2007;9(4):271–6.
13. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the cardiovascular health study. Circulation. 2007;115(18):2390–7.
14. Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int J Cardiovasc Imaging. 2010;26(6):631–40.
15. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56(25):e50–103.
16. Gokce N. Clinical assessment of endothelial function: ready for prime time? Circulation Cardiovascular imaging. 2011;4(4):348–50.
17. Black MA, Cable NT, Thijssen DH, Green DJ. Importance of measuring the time course of flow-mediated dilatation in humans. Hypertension. 2008;51(2):203–10.
18. Weissgerber TL, Davies GA, Tschakovsky ME. Brachial artery flow-mediated dilation is not affected by pregnancy or regular exercise participation. Clin Sci (Lond). 2011;121(8):355–65.
19. Pyke KE, Tschakovsky ME. Peak vs. total reactive hyperemia: which determines the magnitude of flow-mediated dilation? J Appl Physiol. 2007;102(4):1510–9.
20. Gibbs BB, Dobrosielski DA, Lima M, Bonekamp S, Stewart KJ, Clark JM. The association of arterial shear and flow-mediated dilation in diabetes. Vasc Med. 2011;16(4):267–74.
21. Pyke KE, Tschakovsky ME. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol. 2005;568(2):357–69.
22. Woodman RJ, Playford DA, Watts GF, Cheetham C, Reed C, Taylor RR, et al. Improved analysis of brachial artery ultrasound using a novel edge-detection software system. J Appl Physiol. 2001;91(2):929–37.
23. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91(5):1314–9.
24. Gori T, Dragoni S, Lisi M, Di Stolfo G, Sonnati S, Fineschi M, et al. Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function. J Am Coll Cardiol. 2008;51(20):1953–8.
25. Mullen MJ, Kharbanda RK, Cross J, Donald AE, Taylor M, Vallance P, et al. Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia. Circ Res. 2001;88(2):145–51.
26. Spieker LE, Luscher TF, Noll G. ETA receptors mediate vasoconstriction of large conduit arteries during reduced flow in humans. J Cardiovasc Pharmacol. 2003;42(3):315–8.
27. Weissgerber TL, Davies GA, Tschakovsky ME. Low flow-mediated constriction occurs in the radial but not the brachial artery in healthy pregnant and nonpregnant women. J Appl Physiol. 2010;108(5):1097–105.
28. Filitti V, Giral P, Simon A, Merli I, Del Pino M, Levenson J. Enhanced constriction of the peripheral large artery in response to acute induction of a low-flow state in human hypercholesterolemia. Arterioscler Thromb. 1991;11(1):161–6.
29. Parker BA, Ridout SJ, Proctor DN. Age and flow-mediated dilation: a comparison of dilatory responsiveness in the brachial and popliteal arteries. Am J Physiol Heart Circ Physiol. 2006;291(6):H3043–9.
30. Stadler RW, Ibrahim SF, Lees RS. Measurement of the time course of peripheral vasoactivity: results in cigarette smokers. Atherosclerosis. 1998;138(1):197–205.
31. Gori T, Muxel S, Damaske A, Radmacher MC, Fasola F, Schaefer S, et al. Endothelial function assessment: flow-mediated dilation and constriction provide different and complementary information on the presence of coronary artery disease. Eur Heart J. 2012;33(3):363–71.
32. Megnien JL, Simon A, Andriani A, Segond P, Jeannin S, Levenson J. Cholesterol lowering therapy inhibits the low-flow mediated vasoconstriction of the brachial artery in hypercholesterolaemic subjects. Br J Clin Pharmacol. 1996;42(2):187–93.
33. Spiro JR, Digby JE, Ghimire G, Mason M, Mitchell AG, Ilsley C. Brachial artery low-flow-mediated constriction is increased early after coronary intervention and reduces during recovery after acute coronary syndrome: characterization of a recently described index of vascular function. Eur Heart J. 2011;32(7):856–66. This paper examines brachial artery LFMC in patients with non-ST-segment elevation myocardial infarction, before and after percutaneous coronary intervention.
34. Fernandes IA, Sales AR, Rocha NG, Silva BM, Vianna LC, da Nobrega AC. Preserved flow-mediated dilation but delayed time-to-peak diameter in individuals with metabolic syndrome. Clin Physiol Funct Imaging. 2014;34(4):270–6.
35. Irace C, Tschakovsky ME, Carallo C, Cortese C, Gnasso A. Endothelial dysfunction or dysfunctions? Identification of three different FMD responses in males with type 2 diabetes. Atherosclerosis. 2008;200(2):439–45.
36. Liuni A, Luca MC, Lisi M, Dragoni S, di Stolfo G, Mariani JA, et al. Observations of time-based measures of flow-mediated dilation of forearm conduit arteries: implications for the accurate assessment of endothelial function. Am J Physiol Heart Circ Physiol. 2010;299(3):H939–45.
37. Irace C, Padilla J, Carallo C, Scavelli F, Gnasso A. Delayed vasodilation is associated with cardiovascular risk. Eur J Clin Investig. 2014;44(6):549–56.
38. World Health Organization. World Health Report: make every mother, and child count. Geneva: WHO 2005.
39. Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial. Lancet. 2002;359(9321):1877–90.
40. Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Intensification of fetal and maternal surveillance in pregnant women with hypertensive disorders. Int J Gynaecol Obstet. 1998;61(2):127–33.
41. Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol. 2000;95(1):24–8.
42. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–31. This guideline outlines new ACOG criteria for preeclampsia diagnosis.
43. Roberts JM, Lain KY. Recent insights into the pathogenesis of pre-eclampsia. Placenta. 2002;23(5):359–72.
44. Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol. 2003;162(1):115–25.
45. Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2009;30(6):473–82.
46. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association. J Am Coll Cardiol. 2011;57(12):1404–23. This guideline lists preeclampsia as a major risk factor for cardiovascular disease in women.
47. Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(5):1545–88. This guideline identifies preeclampsia as a risk factor for stroke in women.
48. Suboc TM, Dharmashankar K, Wang J, Ying R, Couillard A, Tanner MJ et al. Moderate obesity and endothelial dysfunction in humans: influence of gender and systemic inflammation. Physiol Rep. 2013;1 (3).
49. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010;122(5):478–87.
50. Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet. 2003;361(9368):1511–7.
51. Savvidou MD, Noori M, Anderson JM, Hingorani AD, Nicolaides KH. Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation. Ultrasound Obstet Gynecol. 2008;32(7):871–6.
52. Hamad RR, Eriksson MJ, Berg E, Larsson A, Bremme K. Impaired endothelial function and elevated levels of pentraxin 3 in early-onset preeclampsia. Acta Obstet Gynecol Scand. 2011;91(1):50–6.
53. Yinon Y, Kingdom JC, Odutayo A, Moineddin R, Drewlo S, Lai V, et al. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk. Circulation. 2010;122(18):1846–53.
54. Takase B, Goto T, Hamabe A, Uehata A, Kuroda K, Satomura K, et al. Flow-mediated dilation in brachial artery in the second half of pregnancy and prediction of pre-eclampsia. J Hum Hypertens. 2003;17(10):697–704.
55. Paez O, Alfie J, Gorosito M, Puleio P, de Maria M, Prieto N, et al. Parallel decrease in arterial distensibility and in endothelium-dependent dilatation in young women with a history of pre-eclampsia. Clin Exp Hypertens. 2009;31(7):544–52.
56. Hamad RR, Eriksson MJ, Silveira A, Hamsten A, Bremme K. Decreased flow-mediated dilation is present 1 year after a pre-eclamptic pregnancy. J Hypertens. 2007;25(11):2301–7.
57. Germain AM, Romanik MC, Guerra I, Solari S, Reyes MS, Johnson RJ, et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension. 2007;49(1):90–5.
58. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA. 2001;285(12):1607–12.
59. Ostlund E, Al-Nashi M, Hamad RR, Larsson A, Eriksson M, Bremme K. Normalized endothelial function but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia. Hypertens Res. 2013;36(12):1081–7. This paper shows that the vascular dysfunction observed in women with preeclampsia one year post-partum resolved by 11 years post-partum.
60. Sandvik MK, Leirgul E, Nygard O, Ueland PM, Berg A, Svarstad E et al. Preeclampsia in healthy women and endothelial dysfunction 10 years later. Am J Obstet Gynecol. 2013;209(6):569 e1–e10.
61. Torrado J, Farro I, Farro F, Bia D, Zocalo Y, Sosa C, et al. Carotid-radial pulse wave velocity as an alternative tool for the evaluation of endothelial function during pregnancy: potential role in identifying hypertensive disorders of pregnancy. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:5603–6.
62. Clausen P, Ekbom P, Damm P, Feldt-Rasmussen U, Nielsen B, Mathiesen ER, et al. Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes. J Diabetes Complicat. 2007;21(5):288–93.
63. Brandao AH, Felix LR, do Carmo Patricio E, Leite HV, Cabral AC. Difference of endothelial function during pregnancies as a method to predict preeclampsia. Arch Gynecol Obstet. 2014. DOI 10.1007/s00404-014-3243-3.
64. Garcia RG, Celedon J, Sierra-Laguado J, Alarcon MA, Luengas C, Silva F, et al. Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am J Hypertens. 2007;20(1):98–103.
65. Brodszki J, Lanne T, Laurini R, Strevens H, Wide-Swensson D, Marsal K. Vascular mechanical properties and endothelial function in pre-eclampsia with special reference to bilateral uterine artery notch. Acta Obstet Gynecol Scand. 2008;87(2):154–62.
66. Adali E, Kurdoglu M, Adali F, Cim N, Yildizhan R, Kolusari A. The relationship between brachial artery flow-mediated dilatation, high sensitivity C-reactive protein, and uterine artery Doppler velocimetry in women with pre-eclampsia. J Clin Ultrasound. 2011;39(4):191–7.
67. Mori T, Watanabe K, Iwasaki A, Kimura C, Matsushita H, Shinohara K, et al. Differences in vascular reactivity between pregnant women with chronic hypertension and preeclampsia. Hypertens Res. 2014;37(2):145–50.
68. Tyldum EV, Backe B, Stoylen A, Slordahl SA. Maternal left ventricular and endothelial functions in preeclampsia. Acta Obstet Gynecol Scand. 2011;91(5):566–73.
69. Goynumer G, Yucel N, Adali E, Tan T, Baskent E, Karadag C. Vascular risk in women with a history of severe preeclampsia. J Clin Ultrasound. 2012;41(3):145–50.
70. Mori T, Shinohara K, Wakatsuki A, Watanabe K, Fujimaki A. Adipocytokines and endothelial function in preeclamptic women. Hypertens Res. 2010;33(3):250–4.
71. Yamamoto T, Suzuki Y, Kojima K, Suzumori K. Reduced flow-mediated vasodilation is not due to a decrease in production of nitric oxide in preeclampsia. Am J Obstet Gynecol. 2005;192(2):558–63.
72. Yoshida A, Nakao S, Kobayashi M, Kobayashi H. Flow-mediated vasodilation and plasma fibronectin levels in preeclampsia. Hypertension. 2000;36(3):400–4.
73. Kinzler WL, Smulian JC, Ananth CV, Vintzileos AM. Noninvasive ultrasound assessment of maternal vascular reactivity during pregnancy: a longitudinal study. Obstet Gynecol. 2004;104(2):362–6.
74. Brandao AH, Cabral MA, Leite HV, Cabral AC. Endothelial function, uterine perfusion and central flow in pregnancies complicated by preeclampsia. Arq Bras Cardiol. 2012;99(4):931–5.
75. Anastasakis E, Paraskevas KI, Papantoniou N, Daskalakis G, Mesogitis S, Mikhailidis DP, et al. Association between abnormal uterine artery Doppler flow velocimetry, risk of preeclampsia, and indices of arterial structure and function: a pilot study. Angiology. 2008;59(4):493–9.
76. de Resende Guimaraes MF, Brandao AH, de Lima Rezende CA, Cabral AC, Brum AP, Leite HV et al. Assessment of endothelial function in pregnant women with preeclampsia and gestational diabetes mellitus by flow-mediated dilation of brachial artery. Arch Gynecol Obstet. 2014. DOI 10.1007/s00404-014-3220-x.
77. Kuscu NK, Kurhan Z, Yildirim Y, Tavli T, Koyuncu F. Detection of endothelial dysfunction in preeclamptic patients by using color Doppler sonography. Arch Gynecol Obstet. 2003;268(2):113–6.
78. Vieira MC, da Cunha Filho EV, Paula LG, Hentschke MR, Poli-de-Figueiredo CE, Pinheiro da Costa BE. Flow-mediated dilatation of brachial artery as marker of preeclampsia morbidity. Int J Cardiol. 2013;168(4):4424–5.
79. Filho EV, Mohr C, Filho BJ, Gadonski G, Paula LG, Antonello IC et al. [Flow-mediated dilatation in the differential diagnosis of preeclampsia syndrome]. Arquivos brasileiros de cardiologia. 2010;94 (2):182–6, 95–200, 185–9.